Partner Highlights: September 2021

Blackford Analysis October 10, 2021

Here’s the latest instalment in our news updates from Blackford Platform Partners.

Here’s the latest instalment in our news updates from Blackford Platform Partners. AI-powered breast health solution provider Densitas published a new blog that was posted as part of the company’s series "Leaders in Breast Health". The blog features an interview between Dr Nisha Sharma and Dr Rola Shaheen. Visualization and analytical solutions developer Imaging Biometrics was awarded a European patent for its “dual-echo” technology. The technology, already patented in the USA, is a combined MR acquisition and post-processing technology that allows simultaneous generation of both DSC perfusion and DCE permeability parameters using a single acquisition and eliminates the pre-load dose of gadolinium based contrast agent. This results in a 50% reduction in gadolinium. Neurodegenerative disease assessment specialist Cortechs.ai was pleased to learn that the publication "LesionQuant for Assessment of MRI in Multiple Sclerosis—A Promising Supplement to the Visual Scan Inspection" was added to Frontiers in Neurology's list of Applied Neuroimaging Editor's Picks 2021. The company also posted three new blogs on improved prostate cancer detection, comprehensive volumetric MRI for MS and ARIA screening. And a Cortechs image was selected as one of the finalists in Aunt Minnie’s Best Radiology Image of 2021 competition. Imaging AI specialist icometrix participated at the annual ESNR Meeting in Geneva – a discussion on the future of neuroimaging, advances in MRI and quantitative imaging in neuroradiology practice. The company shared the latest icobrain developments, as well as its publication on ‘Contrast Augmentation Approach to improve Multi-Scanner Generalization in MRI’. icometrix also published a new study on World Alzheimers’ & Dementia Day, focused on the diagnostic value of icobrain dm for AD in routine clinical practice. The study examines how automated volumetric tools are useful to improve diagnostic certainty of AD in routine clinical practice, and how combining brain structures can improve diagnostic accuracy when using real-world imaging data from a clinical setting. Stay tuned for more partner news next month!